The forecasted data for malignant neoplasms mortality rates in Japan show a steady decline from 2024 to 2028, with rates decreasing from 165.4 deaths per hundred thousand persons in 2024 to 156.3 in 2028. This represents an approximate year-on-year decline of around 1.5% over the forecast period. When examining the compound annual growth rate (CAGR) over these five years, there is a consistent reduction in mortality. This reduction is significant given the aging population in Japan, indicating potential advancements in healthcare and early detection measures.
Future trends to watch for include the impact of technological advancements in treatment, preventive healthcare policies, and demographic shifts, which may further influence these mortality rates. Additionally, changes in lifestyle and environmental factors may also play a role in shaping mortality trends from malignant neoplasms.
